HPGC Renmintongtai Pharmaceutical Corporation (600829.SS)

CNY 8.63

(2.49%)

Gross Profit Summary of HPGC Renmintongtai Pharmaceutical Corporation

  • HPGC Renmintongtai Pharmaceutical Corporation's latest annual gross profit in 2023 was 986.11 Million CNY , down -0.88% from previous year.
  • HPGC Renmintongtai Pharmaceutical Corporation's latest quarterly gross profit in 2024 Q3 was 228.57 Million CNY , up 21.84% from previous quarter.
  • HPGC Renmintongtai Pharmaceutical Corporation reported a annual gross profit of 917.53 Million CNY in annual gross profit 2022, down -7.8% from previous year.
  • HPGC Renmintongtai Pharmaceutical Corporation reported a annual gross profit of 995.13 Million CNY in annual gross profit 2021, up 8.54% from previous year.
  • HPGC Renmintongtai Pharmaceutical Corporation reported a quarterly gross profit of 228.57 Million CNY for 2024 Q3, up 21.84% from previous quarter.
  • HPGC Renmintongtai Pharmaceutical Corporation reported a quarterly gross profit of 232.81 Million CNY for 2024 Q1, down -1.04% from previous quarter.

Annual Gross Profit Chart of HPGC Renmintongtai Pharmaceutical Corporation (2023 - 1990)

Historical Annual Gross Profit of HPGC Renmintongtai Pharmaceutical Corporation (2023 - 1990)

Year Gross Profit Gross Profit Growth
2023 986.11 Million CNY -0.88%
2022 917.53 Million CNY -7.8%
2021 995.13 Million CNY 8.54%
2020 916.81 Million CNY -10.19%
2019 1.02 Billion CNY 12.9%
2018 904.13 Million CNY -2.71%
2017 929.31 Million CNY 2.97%
2016 902.5 Million CNY -8.64%
2015 987.89 Million CNY 10.17%
2014 896.68 Million CNY -31.06%
2013 1.3 Billion CNY -36.92%
2012 2.06 Billion CNY 15.51%
2011 1.78 Billion CNY 19.74%
2010 1.49 Billion CNY 14.44%
2009 1.3 Billion CNY -4.79%
2008 1.36 Billion CNY 24.67%
2007 1.09 Billion CNY 12.37%
2006 976.75 Million CNY 15.51%
2005 845.58 Million CNY 223.93%
2004 261.03 Million CNY 83.43%
2003 142.31 Million CNY 0.44%
2002 141.68 Million CNY -5.99%
2001 150.7 Million CNY 13.4%
2000 132.89 Million CNY 29.53%
1999 102.59 Million CNY 12.56%
1998 91.14 Million CNY 15.69%
1997 78.78 Million CNY 0.91%
1996 78.07 Million CNY 15.14%
1995 67.8 Million CNY -75.47%
1994 276.45 Million CNY 211.21%
1993 88.83 Million CNY 28.35%
1992 69.21 Million CNY 18.54%
1991 58.38 Million CNY 21.02%
1990 48.24 Million CNY 0.0%

Peer Gross Profit Comparison of HPGC Renmintongtai Pharmaceutical Corporation

Name Gross Profit Gross Profit Difference
Jiang Zhong Pharmaceutical Co.,Ltd 2.74 Billion CNY 64.113%
Zhejiang Shengda Bio-Pharm Co., Ltd. 74.18 Million CNY -1229.278%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 361.03 Million CNY -173.134%
Nanjing Well Pharmaceutical Group Co.,Ltd. 312.86 Million CNY -215.185%
Ningbo Menovo Pharmaceutical Co., Ltd. 342.7 Million CNY -187.744%
Lionco Pharmaceutical Group Co.,Ltd. 86.95 Million CNY -1034.049%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 659.13 Million CNY -49.607%
ChengDu ShengNuo Biotec Co.,Ltd. 267.6 Million CNY -268.495%
Shanghai Haoyuan Chemexpress Co., Ltd. 759.03 Million CNY -29.918%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 3.59 Billion CNY 72.532%
Yabao Pharmaceutical Group Co., Ltd 1.66 Billion CNY 40.746%
Shanghai Shyndec Pharmaceutical Co., Ltd. 4.39 Billion CNY 77.559%
Hubei Jumpcan Pharmaceutical Co., Ltd. 7.74 Billion CNY 87.268%
Zhongzhu Healthcare Holding Co.,Ltd -114.92 Million CNY 958.037%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 183.75 Million CNY -436.662%
Tibet Weixinkang Medicine Co., Ltd. 672.1 Million CNY -46.722%
Shandong Buchang Pharmaceuticals Co., Ltd. 8.7 Billion CNY 88.669%
Shenzhen Chipscreen Biosciences Co., Ltd. 433.54 Million CNY -127.454%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 765.77 Million CNY -28.773%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 431.02 Million CNY -128.782%
KPC Pharmaceuticals, Inc. 3.33 Billion CNY 70.431%
Shanghai Jiaoda Onlly Co.,Ltd 62.19 Million CNY -1485.491%
Hunan Fangsheng Pharmaceutical Co., Ltd. 1.1 Billion CNY 10.863%
Guobang Pharma Ltd. 1.2 Billion CNY 18.425%
Shanghai Yizhong Pharmaceutical Co., Ltd. 336.2 Million CNY -193.311%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 1.65 Billion CNY 40.422%
Harbin Pharmaceutical Group Co., Ltd. 3.76 Billion CNY 73.822%
Beijing Tongrentang Co., Ltd 8.3 Billion CNY 88.125%
Henan Lingrui Pharmaceutical Co., Ltd. 2.42 Billion CNY 59.37%
Tasly Pharmaceutical Group Co., Ltd 5.66 Billion CNY 82.578%
Kangmei Pharmaceutical Co., Ltd. 715.07 Million CNY -37.904%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 1.32 Billion CNY 25.706%
Humanwell Healthcare (Group) Co.,Ltd. 10.65 Billion CNY 90.745%
China Animal Husbandry Industry Co., Ltd. 1.06 Billion CNY 7.714%
Ginwa Enterprise (Group) Inc. 431.65 Million CNY -128.452%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 1.74 Billion CNY 43.585%
Mayinglong Pharmaceutical Group Co., LTD. 1.3 Billion CNY 24.566%
Henan Taloph Pharmaceutical Stock Co.,Ltd 538.56 Million CNY -83.101%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 2.07 Billion CNY 52.589%
Dali Pharmaceuticalco.,Ltd 36.29 Million CNY -2616.81%
Shandong Lukang Pharmaceutical Co.,Ltd. 1.46 Billion CNY 32.493%
Changchun BCHT Biotechnology Co. 1.6 Billion CNY 38.417%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 528.34 Million CNY -86.641%
Zhejiang Medicine Co., Ltd. 2.52 Billion CNY 60.935%
Zhejiang Huahai Pharmaceutical Co., Ltd. 4.83 Billion CNY 79.609%
Jianmin Pharmaceutical Group Co.,Ltd. 1.88 Billion CNY 47.588%
CanSino Biologics Inc. -876.01 Million CNY 212.568%
Sichuan Huiyu Pharmaceutical Co., Ltd. 787.59 Million CNY -25.206%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 3.61 Billion CNY 72.703%
Hunan Warrant Pharmaceutical Co.,Ltd 928.23 Million CNY -6.236%
Guizhou Yibai Pharmaceutical Co., Ltd. 1.84 Billion CNY 46.469%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 1.9 Billion CNY 48.18%
Joincare Pharmaceutical Group Industry Co.,Ltd. 9.79 Billion CNY 89.933%
North China Pharmaceutical Company Ltd. 3.21 Billion CNY 69.311%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 5.61 Billion CNY 82.439%
Zhejiang Hisun Pharmaceutical Co., Ltd. 4.18 Billion CNY 76.433%
Chongqing Taiji Industry(Group) Co.,Ltd 7.13 Billion CNY 86.184%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 13.54 Billion CNY 92.721%
China National Medicines Corporation Ltd. 3.85 Billion CNY 74.4%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 735.98 Million CNY -33.985%
Cisen Pharmaceutical Co., Ltd. 2.54 Billion CNY 61.323%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 19.8 Billion CNY 95.021%
Zhejiang Starry Pharmaceutical Co.,Ltd. 464.77 Million CNY -112.169%
Tibet Rhodiola Pharmaceutical Holding Co. 2.94 Billion CNY 66.471%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 1.04 Billion CNY 5.544%